Compare $IMUC vs $LTRN | Chartloom

Compare

$IMUC vs $LTRN

Eom Pharmaceutical Holdings Inc · Lantern Pharma Inc

IMUC

Eom Pharmaceutical Holdings Inc

LTRN

Lantern Pharma Inc

Compare $IMUC vs $LTRN

Comparing Eom Pharmaceutical Holdings Inc and Lantern Pharma Inc

IMUCEom Pharmaceutical Holdings Inc

LTRNLantern Pharma Inc

IMUCEom Pharmaceutical Holdings Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.3%

52W performance

-31.7%

FCF yield

-18.9%

LTRNLantern Pharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-73.9%

52W performance

-82.3%

FCF yield

-135.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMUC

LTRN

Detailed metrics comparison

IMUC

Eom Pharmaceutical Holdings Inc

LTRN

Lantern Pharma Inc

Market Cap

IMUC$12M

LTRN$10M

Enterprise Value

IMUC$14M

LTRN$4M

Price

IMUC$0.10

LTRN$0.81

P/E Ratio

IMUCN/A

LTRNN/A

P/S Ratio

IMUC0.00x

LTRN0.00x

EV/Sales

IMUC0.00x

LTRN0.00x

EV/EBITDA

IMUC0.00x

LTRN0.00x

P/B Ratio

IMUC3.51x

LTRN3.19x

P/FCF Ratio

IMUCN/A

LTRNN/A

EV/FCF

IMUC-6.11x

LTRN-0.26x

PEG Ratio

IMUCN/A

LTRNN/A

Forward P/E (NTM)

IMUCN/A

LTRNN/A

Forward P/S (NTM)

IMUCN/A

LTRNN/A

Revenue (TTM)

IMUC$0

LTRN$0

Revenue Growth (YoY)

IMUCN/A

LTRNN/A

Forward Rev Growth

IMUC0.0%

LTRN0.0%

Gross Margin (TTM)

IMUC0.0%

LTRN0.0%

Operating Margin (TTM)

IMUC0.0%

LTRN0.0%

EBITDA Margin (TTM)

IMUC0.0%

LTRN0.0%

Net Margin (TTM)

IMUC0.0%

LTRN0.0%

FCF Margin (TTM)

IMUCN/A

LTRNN/A

Net Income (TTM)

IMUC$-6M

LTRN$-19M

FCF (TTM)

IMUC$-2M

LTRN$-14M

EPS (TTM)

IMUC-$0.05

LTRN-$1.50

ROE (TTM)

IMUC-4502.0%

LTRN-19835.0%

ROA (TTM)

IMUC-45737.0%

LTRN-18428.0%

ROIC (TTM)

IMUC-4502.0%

LTRN-19835.0%

Cash

IMUC$933K

LTRN$7M

Debt

IMUC$3M

LTRN$0

Net Cash/Debt

IMUC$-2M

LTRN$7M

Current Ratio (TTM)

IMUC1.51x

LTRN1.96x

Quick Ratio (TTM)

IMUC1.28x

LTRN1.70x

Debt/Equity (TTM)

IMUC0.00x

LTRN0.00x

Debt/Assets (TTM)

IMUC0.0%

LTRN0.0%

Interest Coverage (TTM)

IMUCN/A

LTRNN/A

Net Debt/EBITDA (TTM)

IMUC0.00x

LTRN0.00x

Beta

IMUC0.80

LTRN2.42

52W Performance

IMUC-31.7%

LTRN-82.3%

YTD Performance

IMUC-51.3%

LTRN-73.9%

% from 52W High

IMUC-72.1%

LTRN-82.7%

% from 52W Low

IMUC375.0%

LTRN6.9%

Asset Turnover (TTM)

IMUC0.00x

LTRN0.00x

FCF Yield (TTM)

IMUC-18.9%

LTRN-135.8%

Earnings Yield (TTM)

IMUC-49.4%

LTRN-179.9%

Dividend Yield (TTM)

IMUCN/A

LTRNN/A

Rule of 40

IMUC0.0

LTRN0.0

EV/GP/RG

IMUCN/A

LTRNN/A

Ticker research

View IMUC research View LTRN research

Metric	IMUC Eom Pharmaceutical Holdings Inc	LTRN Lantern Pharma Inc
Market & Valuation
Market Cap	$12M	$10M
Enterprise Value	$14M	$4M
Price	$0.10	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.51x	3.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.11x	-0.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-19M
FCF (TTM)	$-2M	$-14M
EPS (TTM)	-$0.05	-$1.50
ROE (TTM)	-4502.0%	-19835.0%
ROA (TTM)	-45737.0%	-18428.0%
ROIC (TTM)	-4502.0%	-19835.0%
Financial Health
Cash	$933K	$7M
Debt	$3M	$0
Net Cash/Debt	$-2M	$7M
Current Ratio (TTM)	1.51x	1.96x
Quick Ratio (TTM)	1.28x	1.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	2.42
52W Performance	-31.7%	-82.3%
YTD Performance	-51.3%	-73.9%
% from 52W High	-72.1%	-82.7%
% from 52W Low	375.0%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-18.9%	-135.8%
Earnings Yield (TTM)	-49.4%	-179.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUC research	View LTRN research

Valuation

P/S Ratio

IMUC

0.00x

LTRN

0.00x

EV/FCF

IMUC

-6.11x

LTRN

-0.26x

Growth & revenue

Forward Revenue Growth

IMUC

0.0%

LTRN

0.0%

Profitability & performance

Gross Margin

IMUC

0.0%

LTRN

0.0%

ROE

IMUC

-4502.0%

LTRN

-19835.0%

FCF Yield %

IMUC

-18.9%

LTRN

-135.8%

52-Week Performance

IMUC

-31.7%

LTRN

-82.3%

Detailed metrics comparison

IMUC

Eom Pharmaceutical Holdings Inc

LTRN

Lantern Pharma Inc

Market Cap

IMUC$12M

LTRN$10M

Enterprise Value

IMUC$14M

LTRN$4M

Price

IMUC$0.10

LTRN$0.81

P/E Ratio

IMUCN/A

LTRNN/A

P/S Ratio

IMUC0.00x

LTRN0.00x

EV/Sales

IMUC0.00x

LTRN0.00x

EV/EBITDA

IMUC0.00x

LTRN0.00x

P/B Ratio

IMUC3.51x

LTRN3.19x

P/FCF Ratio

IMUCN/A

LTRNN/A

EV/FCF

IMUC-6.11x

LTRN-0.26x

PEG Ratio

IMUCN/A

LTRNN/A

Forward P/E (NTM)

IMUCN/A

LTRNN/A

Forward P/S (NTM)

IMUCN/A

LTRNN/A

Revenue (TTM)

IMUC$0

LTRN$0

Revenue Growth (YoY)

IMUCN/A

LTRNN/A

Forward Rev Growth

IMUC0.0%

LTRN0.0%

Gross Margin (TTM)

IMUC0.0%

LTRN0.0%

Operating Margin (TTM)

IMUC0.0%

LTRN0.0%

EBITDA Margin (TTM)

IMUC0.0%

LTRN0.0%

Net Margin (TTM)

IMUC0.0%

LTRN0.0%

FCF Margin (TTM)

IMUCN/A

LTRNN/A

Net Income (TTM)

IMUC$-6M

LTRN$-19M

FCF (TTM)

IMUC$-2M

LTRN$-14M

EPS (TTM)

IMUC-$0.05

LTRN-$1.50

ROE (TTM)

IMUC-4502.0%

LTRN-19835.0%

ROA (TTM)

IMUC-45737.0%

LTRN-18428.0%

ROIC (TTM)

IMUC-4502.0%

LTRN-19835.0%

Cash

IMUC$933K

LTRN$7M

Debt

IMUC$3M

LTRN$0

Net Cash/Debt

IMUC$-2M

LTRN$7M

Current Ratio (TTM)

IMUC1.51x

LTRN1.96x

Quick Ratio (TTM)

IMUC1.28x

LTRN1.70x

Debt/Equity (TTM)

IMUC0.00x

LTRN0.00x

Debt/Assets (TTM)

IMUC0.0%

LTRN0.0%

Interest Coverage (TTM)

IMUCN/A

LTRNN/A

Net Debt/EBITDA (TTM)

IMUC0.00x

LTRN0.00x

Beta

IMUC0.80

LTRN2.42

52W Performance

IMUC-31.7%

LTRN-82.3%

YTD Performance

IMUC-51.3%

LTRN-73.9%

% from 52W High

IMUC-72.1%

LTRN-82.7%

% from 52W Low

IMUC375.0%

LTRN6.9%

Asset Turnover (TTM)

IMUC0.00x

LTRN0.00x

FCF Yield (TTM)

IMUC-18.9%

LTRN-135.8%

Earnings Yield (TTM)

IMUC-49.4%

LTRN-179.9%

Dividend Yield (TTM)

IMUCN/A

LTRNN/A

Rule of 40

IMUC0.0

LTRN0.0

EV/GP/RG

IMUCN/A

LTRNN/A

Ticker research

View IMUC research View LTRN research

Metric	IMUC Eom Pharmaceutical Holdings Inc	LTRN Lantern Pharma Inc
Market & Valuation
Market Cap	$12M	$10M
Enterprise Value	$14M	$4M
Price	$0.10	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.51x	3.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.11x	-0.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-19M
FCF (TTM)	$-2M	$-14M
EPS (TTM)	-$0.05	-$1.50
ROE (TTM)	-4502.0%	-19835.0%
ROA (TTM)	-45737.0%	-18428.0%
ROIC (TTM)	-4502.0%	-19835.0%
Financial Health
Cash	$933K	$7M
Debt	$3M	$0
Net Cash/Debt	$-2M	$7M
Current Ratio (TTM)	1.51x	1.96x
Quick Ratio (TTM)	1.28x	1.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	2.42
52W Performance	-31.7%	-82.3%
YTD Performance	-51.3%	-73.9%
% from 52W High	-72.1%	-82.7%
% from 52W Low	375.0%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-18.9%	-135.8%
Earnings Yield (TTM)	-49.4%	-179.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUC research	View LTRN research